Company Filing History:
Years Active: 2021-2025
Title: Nancy Yaneth Villa: Innovator in Cancer Treatment
Introduction
Nancy Yaneth Villa is a prominent inventor based in Scottsdale, AZ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of oncolytic virus platforms. With a total of 3 patents, her work focuses on utilizing myxoma virus to combat various forms of cancer.
Latest Patents
One of her latest patents involves an oncolytic virus platform designed to treat cancers using the myxoma virus. This patent discloses recombinant myxoma viruses (MYXVs) and nucleic acid constructs encoding these viruses. In certain embodiments, the MYXVs are engineered to inactivate or attenuate the activity or expression level of an M153 protein. Additionally, the MYXVs can express transgenes such as tumor necrosis factor (TNF), interleukin-12 (IL-12), or decorin. The patent also outlines methods for using these MYXVs to provide treatment to subjects in need.
Another significant patent focuses on methods of treating cancer with TNF-expressing myxoma virus. This patent describes a method for inhibiting or treating cancer using a TNF-expressing myxoma virus. It also includes methods involving mononuclear peripheral blood cells and/or bone marrow cells treated with the TNF-expressing myxoma virus. The patent emphasizes engineered myxoma viruses and pharmaceutical compositions for use in these treatment methods.
Career Highlights
Nancy has worked with notable institutions such as Arizona State University and Oncomyx Therapeutics, Inc. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative cancer therapies.
Collaborations
Throughout her career, Nancy has collaborated with esteemed colleagues, including Douglas Grant McFadden and Mohammed Masmudur Rahman. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Nancy Yaneth Villa is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for new therapeutic approaches. Her dedication to research and collaboration continues to inspire advancements in medical science.